Insider Buying: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Major Shareholder Purchases $47,640.00 in Stock

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) major shareholder Adar1 Capital Management, Llc bought 3,000 shares of the stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $15.88 per share, with a total value of $47,640.00. Following the purchase, the insider now owns 129,574 shares of […]

Leave a Reply

Your email address will not be published.

Previous post HCA Healthcare, Inc. (NYSE:HCA) Receives $344.06 Average PT from Brokerages
Next post Thomas Demedici Sells 6,304 Shares of Kearny Financial Corp. (NASDAQ:KRNY) Stock